Trevi Therapeutics, Inc. Common Stock TRVI
$18.46
+1.71%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | 8-K | 2026-08-06 | View → |
| 4 | 4 | 2026-06-04 | View → |
| 8-K | 8-K | 2026-06-04 | View → |
| 4 | 4 | 2026-06-04 | View → |
| 4 | 4 | 2026-06-04 | View → |
| 4 | 4 | 2026-06-04 | View → |
| 4 | 4 | 2026-06-04 | View → |
| 10-Q | 10-Q | 2026-05-05 | View → |
| 8-K | 8-K | 2026-05-05 | View → |
| DEF 14A | DEF 14A | 2026-04-21 | View → |
| 424B5 | 424B5 | 2026-04-17 | View → |
| 8-K | 8-K | 2026-04-17 | View → |
| 424B5 | 424B5 | 2026-04-16 | View → |
| 10-K | 10-K | 2026-03-17 | View → |
| 8-K | 8-K | 2026-03-17 | View → |
| 8-K | 8-K | 2026-03-09 | View → |
| 4 | 4 | 2026-02-20 | View → |
| 4 | 4 | 2026-02-20 | View → |
| 4 | 4 | 2026-02-20 | View → |
| 4 | 4 | 2026-02-20 | View → |
| 4 | 4 | 2026-02-20 | View → |
| 4 | 4 | 2026-01-12 | View → |
| 8-K | 8-K | 2025-12-05 | View → |
| 4 | 4 | 2025-12-03 | View → |
| 10-Q | 10-Q | 2025-11-13 | View → |
| 8-K | 8-K | 2025-11-13 | View → |
| 8-K | 8-K | 2025-08-20 | View → |
| 10-Q | 10-Q | 2025-08-07 | View → |
| 8-K | 8-K | 2025-08-07 | View → |
| 8-K | 8-K | 2025-06-17 | View → |
| 4 | 4 | 2025-06-13 | View → |
| 4 | 4 | 2025-06-13 | View → |
| 4 | 4 | 2025-06-13 | View → |
| 4 | 4 | 2025-06-13 | View → |
| 4 | 4 | 2025-06-13 | View → |
| 8-K | 8-K | 2025-06-04 | View → |
| 424B5 | 424B5 | 2025-06-04 | View → |
| 4 | 4 | 2025-06-03 | View → |
| 4 | 4 | 2025-06-03 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $18.46
- Market Cap
- $2.53 billion
- 52-Week Range
- $6.03 – $20.22
- Average Volume
- 2.26 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.